82 related articles for article (PubMed ID: 12390801)
1. [Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy].
Liu Y; Xu DL; Wang MH; Ouyang P; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):114-6. PubMed ID: 12390801
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
3. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
5. [Role of pp60c-src in mitogen-activated protein kinase activation of vascular smooth muscle cells].
Liu D; Lu JS; Yin XL
Sheng Li Xue Bao; 2000 Dec; 52(6):483-6. PubMed ID: 11941412
[TBL] [Abstract][Full Text] [Related]
6. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase.
Moon SK; Jung SY; Choi YH; Lee YC; Patterson C; Kim CH
J Cell Physiol; 2004 Feb; 198(2):310-23. PubMed ID: 14603533
[TBL] [Abstract][Full Text] [Related]
7. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II.
Hou YZ; Yang J; Zhao GR; Yuan YJ
Eur J Pharmacol; 2004 Sep; 499(1-2):85-90. PubMed ID: 15363954
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
9. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
[TBL] [Abstract][Full Text] [Related]
10. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation.
Zhao Y; Liu J; Li L; Liu L; Wu L
Regul Pept; 2005 May; 128(1):43-50. PubMed ID: 15721486
[TBL] [Abstract][Full Text] [Related]
11. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. [Evidence for retinoic acid modulating expression of cyclin-dependent kinase inhibitors in rat hepatic stellate cells].
Huang G; Zhang J; Zhang Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):306-8. PubMed ID: 11676881
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
Zhou CH; Wu XH; Wu YQ
Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
[TBL] [Abstract][Full Text] [Related]
15. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
Tristano AG; Castejon AM; Castro A; Cubeddu LX
Biochem Biophys Res Commun; 2007 Feb; 353(1):11-7. PubMed ID: 17161379
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II suppresses growth arrest specific homeobox (Gax) expression via redox-sensitive mitogen-activated protein kinase (MAPK).
Saito T; Itoh H; Yamashita J; Doi K; Chun TH; Tanaka T; Inoue M; Masatsugu K; Fukunaga Y; Sawada N; Sakaguchi S; Arai H; Tojo K; Tajima N; Hosoya T; Nakao K
Regul Pept; 2005 Apr; 127(1-3):159-67. PubMed ID: 15680482
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells.
Qin XP; Ye F; Hu CP; Liao DF; Deng HW; Li YJ
Eur J Pharmacol; 2004 Mar; 488(1-3):45-9. PubMed ID: 15044034
[TBL] [Abstract][Full Text] [Related]
19. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
20. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
